Showing results (231-240 of 270) with videos related to
Sort By:
Pageof 27
Transfusion|August 23, 2021
Current advances in transfusion medicine 2020: A critical review of selected topics by the AABB Clinical Transfusion Medicine CommitteeElizabeth S Allen, Claudia S Cohn, Sara Bakhtary, et al.Blood|November 14, 2008
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupFrancesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, et al.Transfusion|December 12, 2025
D-Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform-A BEST Collaborative StudyFatima A Aldarweesh, Rim Abdallah, Ingrid Perez Alvarez, et al.Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.American Journal of Hematology|April 8, 2017
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopeniaDavid J Kuter, Barbara A Konkle, Taye H Hamza, et al.JAMA|October 13, 2016
Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and StorageJeffrey L Carson, Gordon Guyatt, Nancy M Heddle, et al.Transfusion|June 1, 2019
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine CommitteeClaudia S Cohn, Elizabeth S Allen, Melissa M Cushing, et al.Blood|September 29, 2021
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITPEun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, et al.Transfusion|May 31, 2020
Current advances in transfusion medicine: a 2019 review of selected topics from the AABB Clinical Transfusion Medicine CommitteeMonica B Pagano, Elizabeth S Allen, Stella T Chou, et al.The Lancet. Haematology|December 22, 2015
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyJames B Bussel, Purificación Garcia de Miguel, Jenny M Despotovic, et al.Pageof 27